Széles, Ádám
Fazekas, Tamás
Váncsa, Szilard
Váradi, Melinda
Kovács, Petra Terézia
Krafft, Ulrich
Grünwald, Viktor
Hadaschik, Boris
Csizmarik, Anita
Hegyi, Péter
Váradi, Alex
Nyirády, Péter
Szarvas, Tibor
Funding for this research was provided by:
New National Excellence Program (ÚNKP-21-3-II-SE-13, ÚNKP-21-5-SE-3)
János Bolyai Research Scholarship of the Hungarian Academy of Sciences (BO/00451/20/5)
Semmelweis University
Article History
Received: 30 August 2022
Accepted: 4 November 2022
First Online: 16 November 2022
Declarations
:
: BH reports personal fees from AAA/Novartis, ABX, Bayer, LightPoint Medical, Inc., Janssen R&D, Bristol–Myers Squibb, and Astellas; research funding from Profound Medical, German Cancer Aid, German Research Foundation, Janssen R&D, Bristol–Myers Squibb, MSD, Pfizer, and Astellas; and travel fees from AstraZeneca, Janssen R&D, and Astellas; all outside the current manuscript. The other authors report none to declare.
: No ethical approval was required for this systematic review with meta-analysis, as all data were already published in peer-reviewed journals. Furthermore, no patients were involved in the design, conduct, or interpretation of our study. The datasets used in this study can be found in the full-text articles included in the systematic review and meta-analysis.